Cash Flow Statement

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Leases Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Preferred Shares Issued Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Other Shares Issued Shares Outstanding Shares Outstanding

Ratios

Atea Pharmaceuticals (AVIR) Receivables - Net (2021 - 2022)

Atea Pharmaceuticals has reported Receivables - Net over the past 2 years, most recently at $4.5 million for Q3 2022.